Celularity CELU
NASDAQ CELU
$1.05 +0.03 (+2.94%)
At close: Oct 22, 2026 · 4:00 PM EDT

Celularity (CELU) Shares Outstanding (Diluted) (2020 - 2026)

Updated

Celularity's Weighted Average Shares Outstanding (Diluted) was 29.34 million in Q2 2026, up 22.2% from 24.02 million a year earlier but down 3.2% from the prior quarter.

Analysis

Celularity (CELU) Shares Outstanding (Diluted) (2020 - 2026) Analysis & Trends

For FY2025, Weighted Average Shares Outstanding (Diluted) at Celularity came in at 25.6 million, up 16.9% from FY2024.

  • Weighted Average Shares Outstanding (Diluted) has now increased for five consecutive years, with a five-year compound annual growth rate of 69.3% (FY2020 to FY2025).
  • In earlier years, Weighted Average Shares Outstanding (Diluted) was 21.89 million in FY2024 (+22.9%), 17.81 million in FY2023 (+18.9%), 14.98 million in FY2022 (+123.4%) and 6.71 million in FY2021 (+264.1%).
  • Quarterly Weighted Average Shares Outstanding (Diluted) has moved between 6.71 million (Q4 2021) and 30.3 million (Q1 2026) over five years.
  • Compared with a year earlier, Weighted Average Shares Outstanding (Diluted) has increased for 20 straight quarters, with growth averaging 18.4% over the last eight quarters.
  • Across the past five years, year-over-year growth in Weighted Average Shares Outstanding (Diluted) ran from 9.7% in Q1 2025 to 608.1% in Q1 2022.
  • Per Business Quant data, CELU's Weighted Average Shares Outstanding (Diluted) in the three quarters before Q2 2026 was 30.3 million (Q1 2026), 25.6 million (Q4 2025) and 26.35 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 893.70 Mn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 2.45 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 1.77 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn 2.47 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 1.56 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 544.00 Mn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn 1.24 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn 5.70 Bn
10 Celularity 30.75 Mn 23.50 Mn 3.09 Mn 29.34 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 29.34 Mn
Mar 31, 2026 30.30 Mn
Dec 31, 2025 25.60 Mn
Sep 30, 2025 26.35 Mn
Jun 30, 2025 24.02 Mn
Mar 31, 2025 23.53 Mn
Dec 31, 2024 21.89 Mn
Sep 30, 2024 21.98 Mn
Jun 30, 2024 21.85 Mn
Mar 31, 2024 21.44 Mn
Dec 31, 2023 17.81 Mn
Sep 30, 2023 18.83 Mn
Jun 30, 2023 17.66 Mn
Mar 31, 2023 15.54 Mn
Dec 31, 2022 14.98 Mn
Sep 30, 2022 15.05 Mn
Jun 30, 2022 15.13 Mn
Mar 31, 2022 13.04 Mn
Dec 31, 2021 6.71 Mn
Sep 30, 2021 12.36 Mn
API Access

Celularity Shares Outstanding (Diluted) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=CELU&period=max&api_key=YOUR_API_KEY